×

What are you searching for?




Business

4 Min read

GSK BUYS STAKE IN GERMAN CORONAVIRUS VACCINE MAKER

Published On 03 Aug 2020 09:56 AM


SHARE THIS ARTICLE  


HIGHLIGHTS

  • GlaxoSmithKline has bought 10% stake worth £ 130 million in CureVac.
  • Stake of 10% is part of deal between two companies that could eventually be worth more than £ 800 million.

The British pharmaceutical company GlaxoSmithKline (GSK) has bought a 10% stake in a German biotech company called CureVac. CureVac is a key player in the global race for a coronavirus....


Tags : GlaxoSmithKline, GSK, CureVac, coronavirus, COVID-19, messenger ribonucleic acid, mRNA, vaccine, Tübingen, UK, Germany, United Kingdom,
SHARE THIS ARTICLE  

Leave a comment 

comments (0)